Goldman Sachs’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,817
| Closed | -$16K | – | 5458 |
|
|
2022
Q3 | $16K | Sell |
3,817
-234
| -6% | -$981 | ﹤0.01% | 5207 |
|
|
2022
Q2 | $21K | Buy |
4,051
+44
| +1% | +$228 | ﹤0.01% | 5416 |
|
|
2022
Q1 | $48K | Sell |
4,007
-2,242
| -36% | -$26.9K | ﹤0.01% | 5478 |
|
|
2021
Q4 | $122K | Sell |
6,249
-699
| -10% | -$13.6K | ﹤0.01% | 5172 |
|
|
2021
Q3 | $181K | Buy |
+6,948
| New | +$181K | ﹤0.01% | 4903 |
|
|
2021
Q2 | – | Sell |
-4,410
| Closed | -$103K | – | 5642 |
|
|
2021
Q1 | $103K | Buy |
+4,410
| New | +$103K | ﹤0.01% | 5030 |
|
|
2019
Q1 | – | Sell |
-540
| Closed | -$25K | – | 4280 |
|
|
2018
Q4 | $25K | Buy |
+540
| New | +$25K | ﹤0.01% | 4016 |
|
|
2018
Q2 | – | Sell |
-6,426
| Closed | -$3.52M | – | 4362 |
|
|
2018
Q1 | $3.52M | Buy |
+6,426
| New | +$3.52M | ﹤0.01% | 2543 |
|
|
2017
Q1 | – | Sell |
-81
| Closed | -$28K | – | 4579 |
|
|
2016
Q4 | $28K | Sell |
81
-20
| -20% | -$6.91K | ﹤0.01% | 4316 |
|
|
2016
Q3 | $34K | Buy |
+101
| New | +$34K | ﹤0.01% | 4370 |
|